LGLCX | RGACX | LGLCX / RGACX | |
Total Expense Ratio | 1.65 | 0.94 | 176% |
Annual Report Gross Expense Ratio | 1.65 | 0.94 | 176% |
Fund Existence | 14 years | 23 years | - |
Gain YTD | 15.448 | 15.516 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1500 | 250 | 600% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.9B | 332B | 2% |
Annual Yield % from dividends | 0.00 | 0.07 | - |
Returns for 1 year | 41.75 | 17.83 | 234% |
Returns for 3 years | 93.46 | 58.53 | 160% |
Returns for 5 years | 24.72 | 40.02 | 62% |
Returns for 10 years | 111.44 | 95.93 | 116% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GTLIX | 21.63 | 0.12 | +0.56% |
Glenmede Disciplined US Eq Ptf InstlShrs | |||
BDSAX | 19.69 | 0.09 | +0.46% |
BlackRock Advantage Small Cap Core Inv A | |||
FAIFX | 27.31 | 0.07 | +0.26% |
American Funds Income Fund of Amer 529F2 | |||
GGHSX | 40.05 | 0.10 | +0.25% |
Invesco Health Care R6 | |||
CPECX | 21.04 | -0.03 | -0.14% |
Catalyst Dynamic Alpha C |